Two grants from the National Institutes of Health will allow Saint Louis University researchers to build on breakthroughs in understanding the hepatitis B virus and begin the search for a drug to cure – not just halt – the illness.
Last year, John Tavis, Ph.D., professor of molecular microbiology and
immunology at SLU published research demonstrating a way to measure and
then block a previously unstudied enzyme, RNAseH, to stop the virus
Armed with that knowledge, Tavis now has the early data and funding
to begin the search for a drug that may help to cure patients with